OpGen

OpGen FCF Margin

The Free Cash Flow Margin of OpGen (OPGN) as of Oct 19, 2026 is -3.92 %. In the previous year, Free Cash Flow Margin was -93.72 % — a change of -95.82% (higher).

FCF Margin

-3.92 %

YoY

-95.82%

Last updated:

Free Cash Flow Margin of OpGen is 2025 -3.92 % . Free Cash Flow Margin of OpGen was 2024 -93.72 % . It decreases by -95.82% higher compared to the previous year.

The OpGen FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-380.92 USD
Jan 1, 2019
-329.73 USD
Jan 1, 2020
-558.30 USD
Jan 1, 2021
-544.89 USD
Jan 1, 2022
-807.08 USD
Jan 1, 2023
-442.36 USD
Jan 1, 2024
-93.72 USD
Jan 1, 2025
-3.92 USD
The OpGen FCF Margin history
YEARFCF MarginYoY
-3.92 %-95.82%
-93.72 %-78.81%
-442.36 %-45.19%
-807.08 %+48.12%
-544.89 %-2.40%
-558.30 %+69.32%
-329.73 %-13.44%
-380.92 %-16.11%
-454.09 %+5.21%
-431.58 %-5.77%
-457.99 %+248.32%
-131.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Free Cash Flow Margin of OpGen is -3.92 % in 2025.

Free Cash Flow Margin of OpGen changed from -93.72 % to -3.92 %, representing a -95.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin OpGen since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's OpGen with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — OpGen

All Key Metrics — OpGen